InClinica, a global, clinical CRO, has opened its new Asia-Pacific office in Kuala Lumpur, along with its subsidiary company, IC LifeSciences.   The new office will serve as InClinica’s Asia-Pacific headquarters for clinical research and life science business development in the region. Jeffrey S. Yablon, executive vice president of InClinica and IC LifeSciences, will serve as the head of this location.   “InClinica prides itself on the depth of our connections around the globe,” said James N...